Table 2.
Neuroimaging variable | Beta value | 95% confidence interval | P-value | MSE |
---|---|---|---|---|
Relative hippocampal volume (n = 192)a | − 0.12 | (− 0.21, − 0.02) | 0.02 | 0.13 |
Hypometabolic convergence index (n = 194) | 0.01 | (0.002, 0.03) | 0.03* | 0.12 |
White matter hyperintensity volume (n = 150) | 0.002 | (− 0.006, 0.01) | 0.56 | 0.12 |
PiB SUVR (n = 110) | 0.06 | (− 0.31, 0.44) | 0.75 | 0.17 |
Tau meta ROI (n = 56) | 0.85 | (− 0.02, 1.77) | 0.07 | 0.12 |
Tau entorhinal SUVR (n = 56) | 0.95 | (0.23, 1.68) | 0.01 | 0.10 |
Tau inferior temporal SUVR (n = 56) | 0.66 | (− 0.08, 1.41) | 0.09 | 0.12 |
Entorhinal cortex thickness (n = 156) | − 0.10 | (− 0.23, 0.02) | 0.11 | 0.14 |
Inferior temporal thickness (n = 156) | − 0.10 | (− 0.20, 0.007) | 0.07 | 0.14 |
Parahippocampal thickness (n = 156) | − 0.25 | (− 0.42, − 0.08) | 0.005 | 0.13 |
All models adjusted for age, sex, education, and APOE ε4 genotype; for PiB SUVR, only 19% of subjects were amyloid positive (SUVR > = 1.47)
aScaled to 1000X; MSE—mean squared error of regression model where values closer to zero indicate better fit. False discovery rate significance level was ɑ = 0.025
*Not statistically significant after FDR adjustment